1Ball GoldCúram craicinnWhite Label Body LotionPraghas ar iarratas 1.6k
2Páirteanna gluaisteánFront and Rear Parking Sensors (Ebat, CarSense, SteelMate)Praghas ar iarratas 1.5k
3Ball GoldFeistí leighis130 mL bottlePraghas ar iarratas 1.5k
4Ball GoldSpóirt foirneNordicLodge 5 m Luxury Cotton Canvas Bell TentPraghas ar iarratas 1.5k
5Ball GoldDeochannaHazelnutsPraghas ar iarratas 1.5k
6Éadaí fearAcid-washed jeans with bleach splatterPraghas ar iarratas 1.5k
7Ball GoldCúram craicinnLG001 — shiny lip glossPraghas ar iarratas 1.4k
8Ball GoldDeochannaMango ChutneyPraghas ar iarratas 1.4k
9Ball GoldSpóirt foirnePAF-X1 Professional Diving MaskPraghas ar iarratas 1.4k
10Ball GoldCúram craicinnPO002 — compact powderPraghas ar iarratas 1.4k
11Ball GoldBoscaí agus cartúinCylindrical box with windowPraghas ar iarratas 1.4k
12Soláthairtí gairdínUF-SP Stainless Steel Stockpot with LidPraghas ar iarratas 1.3k
13Páirteanna gluaisteánSkylon 10 Wiper BladesPraghas ar iarratas 1.3k
14Éadaí fearVintage piece-dyed and acid-washed poloPraghas ar iarratas 1.3k
15Ábhair thógála141+18 viviendas BarakaldoPraghas ar iarratas 1.3k
16Feistí leighisCooling Gel PatchesPraghas ar iarratas 1.3k
17Soláthairtí gairdínRound rattan serving trays, radial weavePraghas ar iarratas 1.3k
18Oiriúintí fóin2201A Power Bank 10000mAh solar and hand crankPraghas ar iarratas 1.2k
19Soláthairtí gairdínUF-MB Stackable Stainless Steel Mixing BowlsPraghas ar iarratas 989
20Oiriúintí fóin2101D Foldable Solar Power Bank 20000mAhPraghas ar iarratas 925
21Ball GoldSpóirt foirneAF1001 Scuba Diving FinsPraghas ar iarratas 721
22Ball GoldSpóirt foirneAeroHaven Modular Inflatable Glamping CabinPraghas ar iarratas 683
23Feistí leighisSlimming PatchesPraghas ar iarratas 651
24Maisiúchán baileRectangular seagrass photo frame, resort stylePraghas ar iarratas 557派安普利(研发代号:AK105)是公司与康方生物科技(开曼)有限公司共同开发的抗PD-1单抗药物。其联合化疗一线治疗局部晚期或转移性鳞状非小细胞肺癌的新药上市申请(NDA)已向中国国家药品监督管理局(NMPA)提交并获得受理,这是派安普利继2020年5月提交治疗至少经过二线系统化疗复发或难治性经典型霍奇金淋巴瘤NDA被NMPA受理后,在中国成功获受理的第二个适应症NDA。此外,派安普利三线治疗转移性鼻咽癌已通过实时肿瘤审评(RTOR)新政策向美国食品药品监督管理局(FDA)提交生物制品许可申请(BLA),并已获FDA授予突破性疗法认定、孤儿药资格认定以及快速审批通道资格。